Top compounds associated with response to TMEM33

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Rapamycin	CTRPv2	pan-cancer	AAC	-0.075	0.03
mRNA	TGX221	GDSC1000	pan-cancer	AAC	-0.11	0.03
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.068	0.03
mRNA	SU11274	CTRPv2	pan-cancer	AAC	-0.076	0.03
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.073	0.03
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.079	0.03
mRNA	AC55649	CTRPv2	pan-cancer	AAC	-0.081	0.03
mRNA	UNC0638	GDSC1000	pan-cancer	AAC	0.065	0.03
mRNA	erlotinib:PLX-4032 (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.081	0.03
mRNA	dabrafenib	GDSC1000	pan-cancer	AAC	0.066	0.03

Download CSV